New model reveals promising insights into Ebola virus researchVesicular stomatitis (VSV), carries a part of the Ebola virus called glycoprotein (GP).
“All animals died within 2-3 days after infection,” the researchers observed, noting that this model could be useful for testing Ebola vaccines.
According to the scientists, this model allowed for quick preclinical testing of Ebola virus countermeasures in BSL-2 conditions.
They added, “This surrogate model is a safe, effective, and cost-efficient tool for rapid preclinical evaluation of medical countermeasures against the Ebola virus under BSL-2 conditions.
It has the potential to accelerate technological advances and breakthroughs in combating Ebola virus disease.”
New model reveals promising insights into Ebola virus research
Vesicular stomatitis (VSV), carries a part of the Ebola virus called glycoprotein (GP). It helps the virus to enter and infect the cells. Five female and five male hamsters that were up to three weeks old died within three days.
They showed symptoms similar to those in Ebola patients, such as weight loss, multi-organ failure, severe eye inflammation, and ulcers. Additionally, the hamsters had high levels of the virus in their bodies.
Scientists are optimistic that this new model could help in future research on Ebola-related eye disorders. “All animals died within 2-3 days after infection,” the researchers observed, noting that this model could be useful for testing Ebola vaccines.
According to the scientists, this model allowed for quick preclinical testing of Ebola virus countermeasures in BSL-2 conditions.
They added, “This surrogate model is a safe, effective, and cost-efficient tool for rapid preclinical evaluation of medical countermeasures against the Ebola virus under BSL-2 conditions. It has the potential to accelerate technological advances and breakthroughs in combating Ebola virus disease.”
